The efficacy of drotrecogin alfa depends on severity of illness.
Deans
Katherine J
KJ
Minneci
Peter C
PC
Eichacker
Peter Q
PQ
Natanson
Charles
C
D018806:APACHE; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D006295:Health Resources / Q000706:statistics & numerical data; D017052:Hospital Mortality; D006801:Humans; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012107:Research Design; D018805:Sepsis / Q000188:drug therapy / Q000401:mortality; D016019:Survival Analysis; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated